A new Beginning..., page-2743

Adding to my wondering, on a probable pivotal Trading Halt any day now for the release of Australian Adult blind trial data and or RAP's Home OSAS sleep study app data release?

I wonder and ponder what Mr Markets response will be to a earlier than expected CE Mark approval on Resapp?

I wonder if there will be over one million uses of RAP's OSAS home sleep app in 22 European countries and Australia in the hands of the public its first year of use at $100 a use?

RAP stated in its latest conference call, the current Australian OSAS sleep study clinical trials are being conducted to American sleep study standards.

RAP's Dr Dr Philip Currie and Professor Udantha Abeyratne are prestigious board members of the American sleep disorder association.

Brisbane, Australia, 11 October 2018 — ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, is pleased to announce positive results from its prospective, double-blind obstructive sleep apnoea (OSA) clinical study. Analysis confirmed that ResApp’s machine-learning algorithms were able to accurately identify OSA from a patient’s overnight breathing and snoring sounds recorded using only a smartphone placed on a bedside table. The company is working with Dr Philip Currie and Dr Ivan Ling of Cardio Respiratory Sleep (CRS) who recruited patients at Hollywood Private Hospital and The Park Private Hospital in Perth, Australia.

I wonder if the OSAS Home sleep study app will have over 20 million uses at $100 a use in USA by the end of 2020?

I wonder what the share price will be if RAP announces a Clinical trial partnership with PING Good Doctor in China after the presentations in China at the end of this month?

I wonder what the PE ratio and share price will be if RAP in 12 months from now is earning the mind boggling revenues I am pondering on?

I wonder if a bigger calculator would be able to work all this out?

I wonder if the current RAP share price represents the potential future earnings?

I wonder if all the multi billion dollar companies that RAP may disrupt would be willing to pay for all my pondered multi billion dollar per year RAP earning potential of what is looking at being the most probable disruptive and history making tech in medical history?

Interesting days ahead...

MB